UPMC Cancer Center - Hillman Cancer Center
Pittsburgh, Pennsylvania 15232
We've found
6 trials
at this facility
Advanced Non-Small Cell Lung Cancer Clinical Trial
Updated: 12/31/1969
A Study of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (MK-3475-495/KEYNOTE-495)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Melanoma Clinical Trial
Updated: 12/31/1969
Dose-seeking Study of Pembrolizumab Plus Vemurafenib and Cobimetinib Advanced Melanoma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Esophageal Neoplasms Clinical Trial
Updated: 12/31/1969
First-line Esophageal Carcinoma Study With Chemo vs. Chemo Plus Pembrolizumab (MK-3475-590/KEYNOTE-590)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Small Lung Cancer, Epigenetic Therapy Clinical Trial
Updated: 12/31/1969
Phase II Anti-PD1 Epigenetic Therapy Study in NSCLC.
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Metastatic Colorectal Cancer Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Pembrolizumab (MK-3475) Plus Binimetinib Alone or Pembrolizumab Plus Chemotherapy With or Without Binimetinib in Metastatic Colorectal Cancer (mCRC) Participants (MK-3475-651)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hepatocellular Carcinoma Clinical Trial
Updated: 12/31/1969
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials